Skip to main content

Share story

Policy

Pentagon moves to designate Anthropic as a supply-chain risk

Pentagon moves to designate Anthropic as a supply-chain risk Image: Primary
President Trump directed federal agencies to cease use of all Anthropic products after the company's public dispute with the Department of Defense. The president allowed for a six-month phase-out period for departments using the products. Secretary of Defense Pete Hegseth directed the Department of War to designate Anthropic a Supply-Chain Risk to National Security. The designation takes effect immediately. No contractor, supplier or partner that does business with the United States military may conduct any commercial activity with Anthropic, the secretary wrote. Anthropic said Friday that while the company has not heard from the government directly, it will challenge any supply chain risk designation in court. The Pentagon dispute centered on Anthropic's refusal to allow its AI models to be used to power either mass domestic surveillance or fully autonomous weapons. Secretary Hegseth found the restrictions unduly restrictive. CEO Dario Amodei reiterated his stance in a public post. He wrote that the company's strong preference is to continue to serve the Department and its warfighters with the two requested safeguards in place and that it will work to enable a smooth transition if the Department chooses to offboard the company.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from TechCrunch and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital
Capital

Nominal raises $240 million at a $3 billion valuation

Nominal has raised $240 million at a $3 billion valuation, triple its valuation in a funding round earlier this year, Bloomberg reports. The startup builds software to make manufacturing more efficient.

Capital Products
Capital Products

Onodrim raises $300M to acquire European defence and industrial suppliers

Amsterdam-based Onodrim Industries has raised $300M in a round led by Lux Capital, valuing the defence group at $1.3bn, the company said Monday. Other investors include General Catalyst, Lakestar and Altimeter. The financing follows its €40M seed round in February.

Capital
Capital

SRTD Biotech raises €31.5 million for targeted RNA therapies

SRTD Biotech has completed an oversubscribed €31.5 million seed financing to develop RNA therapies designed to act selectively inside diseased cells. Mérieux Equity Partners led the round, with NRW.BANK and Boehringer Ingelheim Venture Fund joining as co-leads.